Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat

Epilepsy Research

Volumn 108, Issue 3, 2014, Pages 396-404

  Holtman, Linda ^a   Van Vliet, Erwin A ^a,b   Appeldoorn, Chantal ^c   Gaillard, Pieter J ^c   De Boer, Marco ^c   Dorland, Rick ^c   Wadman, Wytse J ^a,b   Gorter, Jan A ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^c BBB Technologies BV   (Netherlands)

Author keywords

Brain inflammation; Liposomes; Methylprednisolone; Pulse treatment; Temporal lobe epilepsy

Indexed keywords

GLUTATHIONE; GLUTATHIONE PEGYLATED LIPOSOME; LIPOSOME; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; DISEASE DURATION; DRUG BLOOD LEVEL; ELECTROENCEPHALOGRAM; ENCEPHALITIS; EPILEPTIC STATE; EPILEPTOGENESIS; LIMIT OF QUANTITATION; MALE; MICROGLIA; MOSSY FIBER; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPORAL LOBE EPILEPSY;

BRAIN INFLAMMATION; LIPOSOMES; METHYLPREDNISOLONE; PULSE TREATMENT; TEMPORAL LOBE EPILEPSY;

ALBUMINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD11B; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ELECTRODES, IMPLANTED; GLUTATHIONE; HIPPOCAMPUS; MALE; METHYLPREDNISOLONE; MICROGLIA; PHOSPHOLIPIDS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS; TIME FACTORS;

EID: 84895497950     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.01.010     Document Type: Article

References (31)

1. Aronica E., Crino P.B. Inflammation in epilepsy: clinical observations. Epilepsia 2011, 3(52 Suppl.):26-32.
2. Avnir Y., Ulmansky R., Wasserman V., Even-Chen S., Broyer M., Barenholz Y., Naparstek Y. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. Arthritis Rheum. 2008, 58:119-129.
3. Bernards C.M., Akers T. Effect of postinjury intravenous or intrathecal methylprednisolone on spinal cord excitatory amino-acid release, nitric oxide generation, PGE2 synthesis, and myeloperoxidase content in a pig model of acute spinal cord injury. Spinal Cord 2006, 44:594-604.
4. Cavazos J.E., Golarai G., Sutula T.P. Septotemporal variation of the supragranular projection of the mossy fiber pathway in the dentate gyrus of normal and kindled rats. Hippocampus 1992, 2:363-372.
5. Darke K., Edwards S.W., Hancock E., Johnson A.L., Kennedy C.R., Lux A.L., Newton R.W., O'Callaghan F.J., Verity C.M., Osborne J.P. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Arch. Dis. Child. 2010, 95:382-386.
6. Evans M.C., Stolp H.B., Gaillard P.J., de Boer M., Appeldoorn C., Dorland R., Sibson N., Turner M.R., Anthony D.C., 2012. CNS-targeted anti-inflammatory agent reduces pathology in mouse model of ALS. Presented at the 15th Symposium on Signal Transduction in Blood-Brain Barriers, 13-16 September 2012, Potsdam, Germany.
7. Fabene P.F., Navarro Mora G., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 2008, 14::1377-1383.
8. Gaillard P.J. Crossing barriers from blood-to-brain and academia-to-industry. Ther. Deliv. 2010, 1:495-500.
9. Gaillard P.J., Appeldoorn C.C., Rip J., Dorland R., van der Pol S.M., Kooij G., de Vries H.E., Reijerkerk A. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J. Control. Release 2012, 164(3):364-369.
10. Gorter J.A., van Vliet E.A., Aronica E., Breit T., Rauwerda H., Lopes da Silva F.H., Wadman W.J. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J. Neurosci. 2006, 26:11083-11110.
11. Gorter J.A., van Vliet E.A., Aronica E., Lopes da Silva F.H. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur. J. Neurosci. 2001, 13:657-669.
12. Goverman J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9::393-407.
13. Gupta R., Appleton R. Corticosteroids in the management of the paediatric epilepsies. Arch. Dis. Child. 2005, 90:379-384.
14. Karst H., de Kloet E.R., Joels M. Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long-term changes in hippocampal CA1 cells, in the fully kindled state. Eur. J. Neurosci. 1999, 11:889-898.
15. Linker R.A., Weller C., Luhder F., Mohr A., Schmidt J., Knauth M., Metselaar J.M., Gold R. Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations. Exp. Neurol. 2008, 211:397-406.
16. Marchi N., Granata T., Freri E., Ciusani E., Ragona F., Puvenna V., Teng Q., Alexopolous A., Janigro D. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS ONE 2011, 6:e18200.
17. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2011, 16:413-419.
18. McCombe P.A., Henderson R.D. The role of immune and inflammatory mechanisms in ALS. Curr. Mol. Med. 2011, 11:246-254.
19. McMaster A., Ray D.W. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects. Exp. Physiol. 2007, 92::299-309.
20. Ozkara C., Vigevano F. Immuno- and antiinflammatory therapies in epileptic disorders. Epilepsia 2011, 52(Suppl. 3):45-51.
21. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
22. Ravizza T., Lucas S.M., Balosso S., Bernardino L., Ku G., Noe F., Malva J., Randle J.C., Allan S., Vezzani A. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006, 47:1160-1168.
23. Rip J., Chen L., van Kregten J., Dorland R., van der Boom B., de Boer C.A., Gaillard M.P.J. In vitro evaluation and optimization of drug delivery from glutathione-conjugated PEG coated liposomes. 9th International Conference on Cerebral Vascular Biology 2011.
24. Sevilla-Castillo R.A., Palacios G.C., Ramirez-Campos J., Mora-Puga M., Diaz-Bustos R. Methylprednisolone for the treatment of children with refractory epilepsy. Neuropediatrics 2009, 40:265-268.
25. Sloviter R.S. A simplified Timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain. Brain Res. Bull. 1982, 8:771-774.
26. Tischner D., Reichardt H.M. Glucocorticoids in the control of neuroinflammation. Mol. Cell. Endocrinol. 2007, 275:62-70.
27. van Gassen K.L., de Wit M., Koerkamp M.J., Rensen M.G., van Rijen P.C., Holstege F.C., Lindhout D., de Graan P.N. Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 2008, 49:1055-1065.
28. van Vliet E.A., da Costa Araujo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
29. Vezzani A., Bartfai T., Bianchi M., Rossetti C., French J. Therapeutic potential of new antiinflammatory drugs. Epilepsia 2011, 52(Suppl. 8):67-69.
30. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
31. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743.